Anisaldehyde sodium bisulfite adduct
CAS: 33402-67-4
Rif. 3D-IBA40267
1g | Fuori produzione | ||
5g | Fuori produzione | ||
10g | Fuori produzione | ||
250mg | Fuori produzione | ||
500mg | Fuori produzione | ||
2500mg | Fuori produzione |
Informazioni sul prodotto
- 4-Methoxybenzaldehyde sodium metabisulfite adduct
- Anisaldehyde bisulfite
- Benzenemethanesulfonic acid, alpha-hydroxy-4-methoxy-, monosodium salt
- Benzenemethanesulfonic acid, alpha-hydroxy-4-methoxy-, monosodium salt (9CI)
- Benzenemethanesulfonic acid, alpha-hydroxy-4-methoxy-, sodium salt (1:1)
- Benzenemethanesulfonic acid, α-hydroxy-4-methoxy-, monosodium salt
- Benzenemethanesulfonic acid, α-hydroxy-4-methoxy-, sodium salt (1:1)
- Hydroxy(4-Methoxyphenyl)Methanesulfonic Acid
- Nsc 82331
- Sodium Hydroxy(4-Methoxyphenyl)Methanesulfonate
- Vedi altri sinonimi
- Sodium alpha-hydroxy-p-methoxytoluene-alpha-sulphonate
- Sodium α-hydroxy-4-methoxybenzenemethanesulfonate
- alpha-Toluenesulfonic acid, alpha-hydroxy-p-methoxy-, monosodium salt (8CI)
- p-Anisaldehyde bisulfite, sodium salt
- α-Toluenesulfonic acid, α-hydroxy-p-methoxy-, monosodium salt
Anisaldehyde sodium bisulfite adduct is a potent inhibitor of various kinases involved in cell cycle regulation and apoptosis. It has been shown to have anticancer activity in Chinese hamster ovary cells and human cancer cell lines. Anisaldehyde sodium bisulfite adduct is a medicinal compound that has potential as an anticancer drug due to its ability to inhibit the growth of tumor cells by inducing apoptosis. This compound acts as a protein kinase inhibitor, blocking the activity of enzymes involved in cell signaling pathways that regulate proliferation and survival of cancer cells. Anisaldehyde sodium bisulfite adduct may be a promising therapeutic agent for the treatment of various types of cancer.